Skip to menu Skip to content Skip to footer
Professor Antje Blumenthal
Professor

Antje Blumenthal

Email: 
Phone: 
+61 7 344 36984

Overview

Background

Professor Antje Blumenthal combines her expertise in immunology and microbiology to lead research on molecular mechanisms that control immune responses to infection, alongside more recently developed research on new antimicrobials. The overall goal of her research is to improve our ability to treat severe bacterial infections as part of the global efforts to overcome the threat posed by antibiotic-resistant bacteria. Prof Blumenthal graduated with a major in Microbiology from the Christian-Albrechts-University in Kiel, Germany, pursued PhD research in Immunology at the Leibniz Research Center for Medicine and Biosciences Borstel, Germany, and undertook postdoctoral training at Weill Cornell Medical College, New York, USA. She joined The University of Queensland Diamantina Institute in 2010 where she leads the Infection & Inflammation Group, fostering cross-disciplinary collaborations with immunologists, microbiologists, chemists, clinical research teams and industry partners. Her research is enabled by major funding from international and national agencies, and has been recognised internationally and nationally by prestigious awards, speaking invitations at eminent conferences and institutions, invitations to peer-review for esteemed journals and funding agencies. Prof Blumenthal is an enthusiastic undergraduate teacher and research student advisor. She is proactive in advancing the careers of junior scientists, leads the development and implementation of initiatives that promote equity, diversity and inclusion in science, and a positive workplace culture. Through leadership roles within the University and professional societies as well as editorial roles for international journals, Prof Blumenthal actively contributes to the scientific community.

Availability

Professor Antje Blumenthal is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy of Basic and Applied Immunology, University of Lübeck

Research interests

  • Tuberculosis

    - immune response - pathogenesis - novel anti-TB drugs

  • Innate Immunity

    molecular and cellular mechanisms of pathogen recognition, host cell activation and anti-microbial defence

  • Macrophage biology

    infection and inflammation related macrophage functions

  • Inflammation

    molecular regulation of inflammatory responses

  • Sepsis

    immune responses and biomarker discovery

Works

Search Professor Antje Blumenthal’s works on UQ eSpace

93 works between 2000 and 2025

21 - 40 of 93 works

2021

Journal Article

Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial

Gibbons, Kristen S., Schlapbach, Luregn J., Johnson, Kerry, Horton, Stephen B., Long, Debbie A., Beca, John, Erickson, Simon, Festa, Marino, d’Udekem, Yves, Alphonso, Nelson, Winlaw, David, Delzoppo, Carmel, van Loon, Kim, Gannon, Brenda, Fooken, Jonas, Blumenthal, Antje, Young, Paul J., Butt, Warwick and Schibler, Andreas (2021). Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial. Critical Care and Resuscitation, 23 (1), 47-58. doi: 10.51893/2021.1.oa4

Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial

2021

Journal Article

Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial

Gibbons, Kristen S., Schlapbach, Luregn J., Horton, Stephen B., Long, Debbie A., Beca, John, Erickson, Simon, Festa, Marino, d'Udekem, Yves, Alphonso, Nelson, Winlaw, David, Johnson, Kerry, Delzoppo, Carmel, van Loon, Kim, Gannon, Brenda, Fooken, Jonas, Blumenthal, Antje, Young, Paul J., Butt, Warwick and Schibler, Andreas (2021). Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial. Critical Care and Resuscitation, 23 (1), 47-58.

Statistical analysis plan for the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial

2021

Journal Article

Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients (Oncogene, (2020), 39, 35, (5756-5767), 10.1038/s41388-020-01394-w)

Burgess, M., Chen, Y. C.E., Mapp, S., Blumenthal, A., Mollee, P., Gill, D. and Saunders, N. A. (2021). Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients (Oncogene, (2020), 39, 35, (5756-5767), 10.1038/s41388-020-01394-w). Oncogene, 40 (6), 1203-1203. doi: 10.1038/s41388-020-01619-y

Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients (Oncogene, (2020), 39, 35, (5756-5767), 10.1038/s41388-020-01394-w)

2021

Journal Article

SIRPα suppresses response to therapeutic antibodies by nurse like cells from chronic lymphocytic leukemia patients

Chen, Yu-Chen Enya, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje and Saunders, Nicholas A. (2021). SIRPα suppresses response to therapeutic antibodies by nurse like cells from chronic lymphocytic leukemia patients. Frontiers in Immunology, 11 610523, 1-12. doi: 10.3389/fimmu.2020.610523

SIRPα suppresses response to therapeutic antibodies by nurse like cells from chronic lymphocytic leukemia patients

2021

Journal Article

Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection

Domínguez Cadena, Leslie C., Schultz, Thomas E., Zamoshnikova, Alina, Donovan, Meg L., Mathmann, Carmen D., Yu, Chien-Hsiung, Mori, Giorgia, Stow, Jennifer L and Blumenthal, Antje (2021). Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection. Immunology and Cell Biology, 99 (10), 1067-1076. doi: 10.1111/imcb.12503

Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection

2020

Journal Article

Lincolnenins A–D: isomeric bactericidal bianthracenes from Streptomyces lincolnensis

Mohamed, Osama G., Khalil, Zeinab G., Salim, Angela A., Cui, Hui, Blumenthal, Antje and Capon, Robert J. (2020). Lincolnenins A–D: isomeric bactericidal bianthracenes from Streptomyces lincolnensis. The Journal of Organic Chemistry, 86 (16) acs.joc.0c02492, 11011-11018. doi: 10.1021/acs.joc.0c02492

Lincolnenins A–D: isomeric bactericidal bianthracenes from Streptomyces lincolnensis

2020

Journal Article

Septic shock: a genomewide association study and polygenic risk score analysis

D'Urso, Shannon, Rajbhandari, Dorrilyn, Peach, Elizabeth, De Guzman, Erika, Li, Qiang, Medland, Sarah E., Gordon, Scott D., Martin, Nicholas G., Ligthart, Symen, Brown, Matthew A., Powell, Joseph, McArthur, Colin, Rhodes, Andrew, Meyer, Jason, Finfer, Simon, Myburgh, John, Blumenthal, Antje, Cohen, Jeremy, Venkatesh, Balasubramanian, Cuellar-Partida, Gabriel and Evans, David M. (2020). Septic shock: a genomewide association study and polygenic risk score analysis. Twin Research and Human Genetics, 23 (4) PII S1832427420000602, 204-213. doi: 10.1017/thg.2020.60

Septic shock: a genomewide association study and polygenic risk score analysis

2020

Journal Article

HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients

Burgess, M., Chen, U. C. E., Mapp, S., Blumenthal, A., Mollee, P., Gill, D. and Saunders, N. A. (2020). HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients. Oncogene, 39 (35), 5756-5767. doi: 10.1038/s41388-020-01394-w

HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients

2020

Journal Article

Lipopolysaccharide promotes Drp1‐dependent mitochondrial fission and associated inflammatory responses in macrophages

Kapetanovic, Ronan, Afroz, Syeda Farhana, Ramnath, Divya, Lawrence, Grace M.E.P., Okada, Takashi, Curson, James E.B., Bruin, Jost, Fairlie, David P., Schroder, Kate, St John, Justin C., Blumenthal, Antje and Sweet, Matthew J. (2020). Lipopolysaccharide promotes Drp1‐dependent mitochondrial fission and associated inflammatory responses in macrophages. Immunology and Cell Biology, 98 (7) imcb.12363, 528-539. doi: 10.1111/imcb.12363

Lipopolysaccharide promotes Drp1‐dependent mitochondrial fission and associated inflammatory responses in macrophages

2020

Journal Article

Editorial: Wnt signaling in immune cell regulation during microbial infection and cancer

Blumenthal, Antje, Martin-Orozco, Elena, McBride, Jere W., Carson, Dennis A. and Sen, Malini (2020). Editorial: Wnt signaling in immune cell regulation during microbial infection and cancer. Frontiers in Immunology, 11 1133, 1133. doi: 10.3389/fimmu.2020.01133

Editorial: Wnt signaling in immune cell regulation during microbial infection and cancer

2020

Conference Publication

Wntless in myeloid cells drives bleomycin-induced lung pathology

Donovan, C., Kim, R., Gomez, H., Liu, G., Blumenthal, A. and Hansbro, P. (2020). Wntless in myeloid cells drives bleomycin-induced lung pathology. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777

Wntless in myeloid cells drives bleomycin-induced lung pathology

2020

Journal Article

Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2

Das Gupta, Kaustav, Shakespear, Melanie R., Curson, James E.B., Murthy, Ambika M.V., Iyer, Abishek, Hodson, Mark P., Ramnath, Divya, Tillu, Vikas A., von Pein, Jessica B., Reid, Robert C., Tunny, Kathryn, Hohenhaus, Daniel M., Moradi, Shayli Varasteh, Kelly, Gregory M., Kobayashi, Takumi, Gunter, Jennifer H., Stevenson, Alexander J., Xu, Weijun, Luo, Lin, Jones, Alun, Johnston, Wayne A., Blumenthal, Antje, Alexandrov, Kirill, Collins, Brett M., Stow, Jennifer L., Fairlie, David P. and Sweet, Matthew J. (2020). Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2. Cell Reports, 30 (8), 2712-2728.e8. doi: 10.1016/j.celrep.2020.02.007

Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2

2019

Journal Article

Functions of the WNT signaling network in shaping host responses to infection

Ljungberg, Johanna K., Kling, Jessica C., Tran, Thao Thanh and Blumenthal, Antje (2019). Functions of the WNT signaling network in shaping host responses to infection. Frontiers in Immunology, 10 2521, 2521. doi: 10.3389/fimmu.2019.02521

Functions of the WNT signaling network in shaping host responses to infection

2019

Journal Article

Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial

Schlapbach, Luregn J., Horton, Stephen Brian, Long, Debbie Amanda, Beca, John, Erickson, Simon, Festa, Marino, d’Udekem, Yves, Alphonso, Nelson, Winlaw, David, Johnson, Kerry, Delzoppo, Carmel, van Loon, Kim, Gannon, B., Fooken, Jonas, Blumenthal, Antje, Young, Paul, Jones, Mark, Butt, Warwick and Schibler, Andreas (2019). Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial. BMJ Open, 9 (8) e026664, e026664. doi: 10.1136/bmjopen-2018-026664

Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial

2019

Journal Article

Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular

Khalil, Zeinab G., Hill, Timothy A., De Leon Rodriguez, Luis M., Lohman, Rink-Jan, Hoang, Huy N., Reiling, Norbert, Hillemann, Doris, Brimble, Margaret A., Fairlie, David, Blumenthal, Antje and Capon, Robert J. (2019). Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular. Antimicrobial Agents and Chemotherapy, 63 (3) e01773-18. doi: 10.1128/AAC.01773-18

Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular

2019

Journal Article

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

Enya Chen, Yu-Chen, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje and Saunders, Nicholas A. (2019). PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia. Leukemia, 34 (2), 451-461. doi: 10.1038/s41375-019-0556-z

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

2018

Journal Article

Temporal regulation of natural Killer T cell interferon gamma responses by beta-catenin-dependent and -independent Wnt signaling

Kling, Jessica C., Jordan, Margaret A., Pitt, Lauren A., Meiners, Jana, Thanh-Tran, Thao , Tran, Le Son , Nguyen, Tam T. K., Mittal, Deepak, Villani, Rehan, Steptoe, Raymond J., Khosrotehrani, Kiarash, Berzins, Stuart P., Baxter, Alan G., Godfrey, Dale I. and Blumenthal, Antje (2018). Temporal regulation of natural Killer T cell interferon gamma responses by beta-catenin-dependent and -independent Wnt signaling. Frontiers in Immunology, 9 (MAR) 483, 483. doi: 10.3389/fimmu.2018.00483

Temporal regulation of natural Killer T cell interferon gamma responses by beta-catenin-dependent and -independent Wnt signaling

2018

Journal Article

Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection

Chamoun, Michelle N., Blumenthal, Antje, Sullivan, Matthew J., Schembri, Mark A. and Ulett, Glen C. (2018). Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection. Critical Reviews in Microbiology, 44 (4), 1-22. doi: 10.1080/1040841X.2018.1426556

Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection

2018

Journal Article

The N-terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105-agonistic properties

Schultz, Thomas E., Wiesmüller, Karl-Heinz, Lucas, Megan, Dobos, Karen M., Baxter, Alan G. and Blumenthal, Antje (2018). The N-terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105-agonistic properties. Journal of Leukocyte Biology, 103 (2), 311-319. doi: 10.1002/JLB.2MA0517-190RR

The N-terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105-agonistic properties

2018

Conference Publication

Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta

Chen, Yu-Chen Enya, Burgess, Melinda Lea, Blumenthal, Antje, Mapp, Sally, Mollee, Peter, Gill, Devinder and Saunders, Nicholas Andrew (2018). Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta. 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA United States, 1-4 December 2018. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2018-99-109719

Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta

Funding

Current funding

  • 2025 - 2028
    Preclinical validation of anti-tubercular conjugated oligoelectrolytes
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2026
    Improving tuberculosis diagnosis and care through functional immune screening
    TRI Leading Innovations through New Collaborations Scheme
    Open grant
  • 2024 - 2027
    Molecular drivers of metabolic reprogramming in Mycobacterium tuberculosis infection
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2026
    New Frontiers in Innate Immunity
    ARC Future Fellowships
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Host Gene Expression Signatures to Diagnose Sepsis in Children
    MRFF Genomics Health Futures Mission, Project Grant administered by AusIndustry
    Open grant

Past funding

  • 2022 - 2023
    Molecular regulators of inflammation
    The American Association of Immunologists Careers in Immunology Fellowship
    Open grant
  • 2022 - 2024
    Can blood RNA signatures improve the diagnosis of latent tuberculosis in solid organ transplant recipients? (2022 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Hospital and Health Service
    Open grant
  • 2021
    Controlling the enemy within: What makes macrophages restrict or promote Mycobacterium tuberculosis growth in vivo
    GeoMx Whole Transcriptome Atlas Neuroscience Grant
    Open grant
  • 2021 - 2024
    Diagnostic utility of tests of latent tuberculosis in immune compromised contacts exposed to multi-drug resistant tuberculosis (2021 Metro South SERTA Novice Researcher Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Enhancing host defence to combat bacterial infections (2020 Georgina Sweet Award)
    Georgina Sweet Award for Women in Quantitative Biomedical Science
    Open grant
  • 2020 - 2023
    Molecular regulators of inflammation during Gram-negative bacterial infection
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2022
    Nitric Oxide to improve recovery and survival in neonates and children on Extracorporeal Life Support - a pilot randomized controlled trial (the NECTAR trial)
    The Children's Hospital Foundation
    Open grant
  • 2019 - 2022
    Vascular responsiveness in septic shock (NHMRC Project Grant led by UNSW)
    University of New South Wales
    Open grant
  • 2018 - 2020
    RAPIDS TRIAL: Rapid Acute Paediatric Infection Diagnosis in Suspected Sepsis
    Gold Coast Hospital and Health Services
    Open grant
  • 2018 - 2023
    Preclinical Validation of a Novel Drug Lead to Treat Tuberculosis
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2018 - 2020
    Enhancing host defence mechanisms in severe bacterial infections
    NHMRC Project Grant
    Open grant
  • 2018 - 2021
    Nitric Oxide on Cardio Pulmonary Bypass in Congenital Heart Disease
    NHMRC Project Grant
    Open grant
  • 2017 - 2019
    Reducing morbidity and mortality in infants and children after cardiopulmonary bypass - a multicenter randomized controlled trial
    The Children's Hospital Foundation
    Open grant
  • 2017 - 2019
    Innate immune signalling in Mycobacterium tuberculosis infection
    NHMRC Project Grant
    Open grant
  • 2016 - 2019
    Developing new antibiotics to treat tuberculosis
    Australian Tropical Medicine Commercialisation Programme
    Open grant
  • 2016 - 2019
    Cellular regulation of receptor signalling and cytokine responses
    NHMRC Project Grant
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2017
    Towards biomarkers for patient stratification in sepsis
    TRI Spore Grants
    Open grant
  • 2015 - 2016
    Identifying Protective v Pathogenic Macrophages in Chronic Liver Disease: Critical for Macrophage-Targeted Therapy
    PA Research Foundation
    Open grant
  • 2014
    Multiplex High Throughput Bio-plex Protein Assay Platform
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    Targeting the Wnt Pathway: Implication for Chronic Liver disease
    PA Research Foundation
    Open grant
  • 2013 - 2014
    ResTeach 2013 0.1 FTE School of Chemistry and Molecular Biosciences
    UQ ResTeach
    Open grant
  • 2013 - 2016
    RP105 is a new innate immune receptor for Mycobacterium tuberculosis
    NHMRC Project Grant
    Open grant
  • 2011 - 2012
    Immune modulation by Wnt/B-Catenin signalling during bacterial infection
    UQ Early Career Researcher
    Open grant
  • 2011
    Laser Scanner for Biomolecular Imaging
    NHMRC Equipment Grant
    Open grant

Supervision

Availability

Professor Antje Blumenthal is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Mapping cellular signalling pathways in mycobacteria-infected macrophages

    Principal Advisor

    Other advisors: Dr Tom Schultz, Dr Carmen Mathmann

  • Doctor Philosophy

    Molecular regulators of macrophage functions during Mycobacterium tuberculosis infection

    Principal Advisor

    Other advisors: Dr Carmen Mathmann

  • Doctor Philosophy

    Characterisation of the anti-mycobacterial activity of wollamide cyclic hexapeptides against Mycobacterium tuberculosis

    Principal Advisor

    Other advisors: Associate Professor Timothy Wells

  • Doctor Philosophy

    Investigating molecular mechanisms of RP105-dependent macrophage activation during mycobacterial infection

    Principal Advisor

    Other advisors: Professor Matt Sweet, Dr Tom Schultz

  • Doctor Philosophy

    Impact of nitric oxide on inflammation and coagulation in patients undergoing extracorporeal membrane oxygenation (ECMO)

    Principal Advisor

    Other advisors: Dr Craig McBride

  • Doctor Philosophy

    Microbiome-host-interactions in Mycobacterium tuberculosis infection

    Principal Advisor

    Other advisors: Professor Mark Morrison

  • Doctor Philosophy

    The Gut-Lung axis in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

    Associate Advisor

    Other advisors: Professor Mark Morrison, Professor Rachel Thomson

  • Doctor Philosophy

    Transmission dynamics of multi-drug resistant tuberculosis amongst immune suppressed patients exposed to an infectious case

    Associate Advisor

    Other advisors: Honorary Professor John Upham, Professor Rachel Thomson

  • Master Philosophy

    The gut-lung axis in nontuberculous mycobacterial pulmonary disease.

    Associate Advisor

    Other advisors: Professor Mark Morrison, Professor Rachel Thomson

  • Master Philosophy

    The gut-lung axis in nontuberculous mycobacterial pulmonary disease.

    Associate Advisor

    Other advisors: Professor Mark Morrison, Professor Rachel Thomson

  • Doctor Philosophy

    Functions of CSF1R signalling in inflammation.

    Associate Advisor

    Other advisors: Professor David Hume, Dr Katharine Irvine

Completed supervision

Media

Enquiries

Contact Professor Antje Blumenthal directly for media enquiries about their areas of expertise.

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au